[1]
“Pharmacotherapeutic profile and quality of life in people with Systemic Lupus Erythematosus”, Rev. Cont. Saúde, vol. 23, no. 47, p. e12115, Sep. 2023, doi: 10.21527/2176-7114.2023.47.12115.